Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Sep-23 4:47 PM View:  | Syros Pharmaceuticals, Inc. (SYRS) | 16-Sep-23 | Option Exercise | 2,666 | -- | -- | 267% 1.0K to 3.67K | |
| 24-May-23 6:23 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 23-May-23 | Grant | 4,190 | -- | -- | 38% 10.9K to 15.1K | |
| 02-Nov-22 6:42 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 31-Oct-22 | Market Purchase | 3,625 | $86.75 | $314,469.00 | 50% 7.28K to 10.9K | (3%) |
| 17-Aug-22 4:32 PM View: | Turning Point Therapeutics,... (TPTX) | 17-Aug-22 | Disposition | 2,000 | $76.00 | $152,000.00 | (100%) 2.0K to 0 | |
| 26-May-22 8:12 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 24-May-22 | Grant | 4,980 | -- | -- | 217% 2.3K to 7.28K | |
| 05-Jan-22 6:09 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 03-Jan-22 | Grant | 2,300 | -- | -- | 100% 0 to 2.3K | |
| 21-Jun-21 9:14 PM View: | Turning Point Therapeutics,... (TPTX) | 21-Jun-21 | Market Purchase | 2,000 | $81.34 | $162,680.00 | 100% 0 to 2.0K | (< 1%) |
| 13-May-20 5:05 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 13-May-20 | Market Purchase | 10,000 | $8.86 | $88,590.00 | 100% 0 to 10.0K | 32% |
| 22-Nov-19 7:31 AM View: | Celgene Corporation (CELG) | 20-Nov-19 | Grant | 145,229 | -- | -- | 64% 227.52K to 372.75K | |
| 22-Nov-19 7:31 AM View: | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 366,495 | -- | -- | (98%) 372.75K to 6.25K | |
| 22-Nov-19 7:31 AM View: | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 6,252 | -- | -- | (100%) 6.25K to 0 | |
| 06-May-19 4:05 PM View: | Celgene Corporation (CELG) | 02-May-19 | Payment of Exercise | 6,620 | $95.21 | $630,290.00 | (3%) 234.14K to 227.52K | |
| 06-May-19 4:05 PM View: | Celgene Corporation (CELG) | 02-May-19 | Option Exercise | 15,608 | -- | -- | 7% 218.53K to 234.14K | |
| 05-Mar-19 4:05 PM View: | Celgene Corporation (CELG) | 01-Mar-19 | Payment of Exercise | 13,900 | $85.96 | $1,194,840.00 | (6%) 232.23K to 218.33K | |
| 05-Mar-19 4:05 PM View: | Celgene Corporation (CELG) | 01-Mar-19 | Option Exercise | 33,809 | -- | -- | 17% 198.43K to 232.23K | |
| 18-Dec-18 6:25 PM View: | Celgene Corporation (CELG) | 16-Dec-18 | Payment of Exercise | 3,876 | $68.20 | $264,343.00 | (2%) 202.3K to 198.43K | (33%) |
| 18-Dec-18 6:25 PM View: | Celgene Corporation (CELG) | 16-Dec-18 | Option Exercise | 8,929 | -- | -- | 5% 193.37K to 202.3K | |
| 17-May-18 4:08 PM View: | Celgene Corporation (CELG) | 09-May-18 | Market Purchase | 1,208 | $82.60 | $99,784.40 | < 1% 192.16K to 193.37K | 10% |
| 08-May-18 4:30 PM View: | Celgene Corporation (CELG) | 04-May-18 | Payment of Exercise | 1,519 | $86.89 | $131,986.00 | (< 1%) 193.68K to 192.16K | (4%) |
| 08-May-18 4:30 PM View: | Celgene Corporation (CELG) | 04-May-18 | Option Exercise | 3,500 | -- | -- | 2% 190.18K to 193.68K | |
| 20-Feb-18 5:00 PM View: | Celgene Corporation (CELG) | 17-Feb-18 | Payment of Exercise | 2,060 | $95.26 | $196,236.00 | (1%) 192.11K to 190.05K | 5% |
| 20-Feb-18 5:00 PM View: | Celgene Corporation (CELG) | 17-Feb-18 | Option Exercise | 7,283 | -- | -- | 4% 184.83K to 192.11K | |
| 08-Feb-18 4:47 PM View: | Celgene Corporation (CELG) | 08-Feb-18 | Market Purchase | 3,260 | $91.90 | $299,594.00 | 2% 181.57K to 184.83K | (1%) |
| 20-Dec-17 4:02 PM View: | Celgene Corporation (CELG) | 19-Dec-17 | Payment of Exercise | 2,094 | $107.06 | $224,184.00 | (1%) 183.66K to 181.57K | 15% |
| 20-Dec-17 4:02 PM View: | Celgene Corporation (CELG) | 19-Dec-17 | Option Exercise | 4,550 | -- | -- | 3% 179.11K to 183.66K | |
| 01-Aug-17 4:48 PM View: | Celgene Corporation (CELG) | 28-Jul-17 | Payment of Exercise | 1,932 | $134.10 | $259,081.00 | (1%) 181.04K to 179.11K | 32% |
| 01-Aug-17 4:48 PM View: | Celgene Corporation (CELG) | 28-Jul-17 | Option Exercise | 4,200 | -- | -- | 2% 176.84K to 181.04K | |
| 16-Feb-17 5:07 PM View: | Celgene Corporation (CELG) | 14-Feb-17 | Grant | 14,447 | -- | -- | 9% 168.89K to 183.34K | |
| 16-Feb-17 5:07 PM View: | Celgene Corporation (CELG) | 14-Feb-17 | Payment of Exercise | 6,643 | $117.02 | $777,364.00 | (4%) 183.34K to 176.69K | 22% |
| 06-Dec-16 4:03 PM View: | Celgene Corporation (CELG) | 02-Dec-16 | Payment of Exercise | 3,018 | $117.63 | $355,007.00 | (2%) 171.91K to 168.89K | 23% |
| 06-Dec-16 4:03 PM View: | Celgene Corporation (CELG) | 02-Dec-16 | Option Exercise | 6,560 | -- | -- | 4% 165.35K to 171.91K | |
| 03-May-16 4:30 PM View: | Celgene Corporation (CELG) | 29-Apr-16 | Payment of Exercise | 5,062 | $103.41 | $523,461.00 | (3%) 170.41K to 165.35K | 12% |
| 03-May-16 4:30 PM View: | Celgene Corporation (CELG) | 29-Apr-16 | Option Exercise | 11,000 | -- | -- | 7% 159.41K to 170.41K | |
| 16-Feb-16 10:00 PM View: | Celgene Corporation (CELG) | 12-Feb-16 | Grant | 25,840 | -- | -- | 18% 145.32K to 171.16K | |
| 16-Feb-16 10:00 PM View: | Celgene Corporation (CELG) | 12-Feb-16 | Payment of Exercise | 11,889 | $102.45 | $1,218,030.00 | (7%) 171.16K to 159.28K | 11% |
| 02-Feb-16 4:46 PM View: | Celgene Corporation (CELG) | 29-Jan-16 | Option Exercise | 21,938 | $27.51 | $603,586.00 | 18% 123.39K to 145.32K | |
| 18-Dec-15 4:19 PM View: | Celgene Corporation (CELG) | 17-Dec-15 | Payment of Exercise | 5,370 | $112.17 | $602,353.00 | (4%) 128.76K to 123.39K | 19% |
| 18-Dec-15 4:19 PM View: | Celgene Corporation (CELG) | 17-Dec-15 | Option Exercise | 11,670 | -- | -- | 10% 117.09K to 128.76K | |
| 04-May-15 7:13 PM View: | Celgene Corporation (CELG) | 30-Apr-15 | Payment of Exercise | 5,154 | $108.06 | $556,941.00 | (4%) 122.24K to 117.09K | 16% |
| 04-May-15 7:13 PM View: | Celgene Corporation (CELG) | 30-Apr-15 | Option Exercise | 11,200 | -- | -- | 10% 111.04K to 122.24K | |
| 03-Mar-15 4:22 PM View: | Celgene Corporation (CELG) | 01-Mar-15 | Payment of Exercise | 4,078 | $121.53 | $495,599.00 | (4%) 115.12K to 111.04K | 25% |
| 03-Mar-15 4:22 PM View: | Celgene Corporation (CELG) | 01-Mar-15 | Option Exercise | 8,334 | -- | -- | 8% 106.78K to 115.12K | |
| 17-Feb-15 4:44 PM View: | Celgene Corporation (CELG) | 12-Feb-15 | Option Exercise | 27,505 | $45.43 | $1,249,650.00 | 35% 79.28K to 106.78K | |
| 10-Feb-15 6:46 PM View: | Celgene Corporation (CELG) | 06-Feb-15 | Grant | 30,404 | -- | -- | 42% 71.6K to 102.01K | |
| 10-Feb-15 6:46 PM View: | Celgene Corporation (CELG) | 06-Feb-15 | Payment of Exercise | 13,666 | $118.75 | $1,622,840.00 | (7%) 209.87K to 196.2K | 24% |
| 10-Feb-15 6:46 PM View: | Celgene Corporation (CELG) | 06-Feb-15 | Option Exercise | 107,859 | $41.75 | $4,503,110.00 | 106% 102.01K to 209.87K | |
| 10-Feb-15 6:46 PM View: | Celgene Corporation (CELG) | 06-Feb-15 | Market Option Sale | 107,859 | $120.68 | $13,016,100.00 | (55%) 196.2K to 88.34K | 25% |
| 10-Feb-15 6:46 PM View: | Celgene Corporation (CELG) | 06-Feb-15 | Market Sale | 9,240 | $120.68 | $1,115,060.00 | (10%) 88.34K to 79.1K | 25% |
| 14-Feb-14 4:57 PM View: | Celgene Corporation (CELG) | 12-Feb-14 | Grant | 15,188 | -- | -- | 56% 27.33K to 42.52K | |
| 14-Feb-14 4:57 PM View: | Celgene Corporation (CELG) | 12-Feb-14 | Payment of Exercise | 6,837 | $160.54 | $1,097,610.00 | (16%) 42.52K to 35.69K | (13%) |